Search Results 1991-2000 of 18752 for Relapse
... Relapsed/Refractory Leiomyosarcoma (LMS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
* Relapsed/refractory following treatment with hydroxyurea; or at least 4 cycles of treatment with hypomethylating agents; or who are intolerant of ...
This medicine will not cure multiple sclerosis, but may extend the time between relapses. This medicine is available only with your doctor's prescription ...
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. Peginterferons are natural ...
Memory lapses and modest decline in thinking skills are common as people age. There's a difference, however, between normal changes in memory and memory ...
... relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen View PubMed; Lehman VT, Diehn FE, Broski SM, Nathan ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes ...
* Histologically confirmed multiple myeloma that is exposed, relapsed, or intolerant to one of each of the following classes of agents: * A proteasome inhibitor
"Currently there are six different CAR-T cell therapies approved for treatment of relapsed blood cancers. While the results are impressive, not everyone ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.